Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05086939
PHASE3

Multicenter Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis.

Sponsor: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

View on ClinicalTrials.gov

Summary

Phase III, multicenter, randomized, open-label, multicenter clinical trial comparing treatment with allogeneic mesenchymal cells versus autologous mesenchymal cells and versus active control with hyaluronic acid in patients with knee osteoarthritis.

Official title: Phase III, Multicenter, Randomized, Open-label Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

124

Start Date

2021-05-26

Completion Date

2026-05

Last Updated

2024-11-29

Healthy Volunteers

No

Interventions

DRUG

Autologous MSCs

Intra-articular injection 40 million/4 ml.

DRUG

Allogenic MSCs

Intra-articular injection 40 million/4 ml.

DRUG

Hyaluronic Acid

Intra-articular injection 60mg / 3 ml .

Locations (8)

Hospital Clinic

Barcelona, Spain

Hospital Clínico Universitario San Carlos

Madrid, Spain

Hospital Fundación Jiménez Díaz

Madrid, Spain

Hospital Gregorio Marañón

Madrid, Spain

Hospital Universitario Virgen de la Victoria

Málaga, Spain

Hospital Universitario Virgen de la Arrixaca

Murcia, Spain

Clínica Universidad de Navarra

Pamplona, Spain

Complejo Asistencial Universitario de Salamanca

Salamanca, Spain